Literature DB >> 29937340

Contrast-enhanced spectral mammography (CESM).

J J James1, S L Tennant2.   

Abstract

Contrast-enhanced spectral mammography (CESM) is a valuable tool in the diagnosis and staging of primary breast cancer. It combines an iodinated contrast agent with conventional mammography to improve diagnostic accuracy, particularly in women with denser parenchymal background patterns. This review describes the CESM technique, reviews performance compared to conventional mammography and magnetic resonance imaging, assesses its role in the diagnosis and staging of primary breast cancer, and investigates its potential as a screening tool.
Copyright © 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29937340     DOI: 10.1016/j.crad.2018.05.005

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  16 in total

1.  Dual-energy contrast-enhanced spectral mammography (CESM) for breast cancer screening.

Authors:  Vera Sorin; Miri Sklair-Levy
Journal:  Quant Imaging Med Surg       Date:  2019-11

2.  The emerging role of contrast-enhanced mammography.

Authors:  Andrea Cozzi; Simone Schiaffino; Francesco Sardanelli
Journal:  Quant Imaging Med Surg       Date:  2019-12

3.  Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.

Authors:  Rosaria Meucci; Chiara Adriana Pistolese; Tommaso Perretta; Gianluca Vanni; Emanuela Beninati; Federica DI Tosto; Maria Lina Serio; Aurelia Caliandro; Marco Materazzo; Marco Pellicciaro; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

4.  Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging.

Authors:  Maria Adele Marino; Doris Leithner; Janice Sung; Daly Avendano; Elizabeth A Morris; Katja Pinker; Maxine S Jochelson
Journal:  Diagnostics (Basel)       Date:  2020-07-18

5.  The diagnostic value of contrast-enhanced 2D mammography in everyday clinical use.

Authors:  L M F H Neeter; H P J Raat; S D Meens-Koreman; R S A van Stiphout; S M E C Timmermans; K M Duvivier; M L Smidt; J E Wildberger; P J Nelemans; M B I Lobbes
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

6.  Diagnostic Accuracy of Contrast-Enhanced, Spectral Mammography (CESM) and 3T Magnetic Resonance Compared to Full-Field Digital Mammography plus Ultrasound in Breast Lesions: Results of a (Pilot) Open-Label, Single-Centre Prospective Study.

Authors:  Francesca Romana Ferranti; Federica Vasselli; Maddalena Barba; Francesca Sperati; Irene Terrenato; Franco Graziano; Patrizia Vici; Claudio Botti; Antonello Vidiri
Journal:  Cancers (Basel)       Date:  2022-03-07       Impact factor: 6.639

7.  Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size.

Authors:  Luca Nicosia; Anna Carla Bozzini; Antuono Latronico; Enrico Cassano
Journal:  Korean J Radiol       Date:  2020-09-10       Impact factor: 3.500

8.  Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers.

Authors:  Zhongyi Wang; Fan Lin; Heng Ma; Yinghong Shi; Jianjun Dong; Ping Yang; Kun Zhang; Na Guo; Ran Zhang; Jingjing Cui; Shaofeng Duan; Ning Mao; Haizhu Xie
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

9.  Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis.

Authors:  Matteo Basilio Suter; Filippo Pesapane; Giorgio Maria Agazzi; Tania Gagliardi; Olga Nigro; Anna Bozzini; Francesca Priolo; Silvia Penco; Enrico Cassano; Claudio Chini; Alessandro Squizzato
Journal:  Breast       Date:  2020-06-10       Impact factor: 4.380

Review 10.  Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.

Authors:  Ella F Jones; Deep K Hathi; Rita Freimanis; Rita A Mukhtar; A Jo Chien; Laura J Esserman; Laura J Van't Veer; Bonnie N Joe; Nola M Hylton
Journal:  Cancers (Basel)       Date:  2020-06-09       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.